Pascual Innoventures, founded in 2021 to promote the food of the future, has already made its first significant capital investment demonstrating its clear commitment to innovation and fulfilling its goal to help to develop the milk of the future. Specifically, it has invested in De Novo Dairy and Zero Cow Factory, two of the four startups that were part of the first cohort of Mylkcubator, the first incubator in the world specialized in the development of innovation projects for the dairy sector, launched by Pascual Innoventures in partnership with Eatable Adventures.
De Novo Dairy and Zero Cow Factory, highly innovative, are specialized in the development of cellular agriculture and precision fermentation technologies, a segment currently gaining traction in the dairy sector. These technologies, capable of directly producing nutrients and ingredients for the dairy industry through microorganisms, sum up and complement the traditional industry, helping industry players move towards increasingly sustainable, efficient, and healthy mixed production models that ensure food security for everyone.
De Novo Dairy, based in South Africa, is focused on developing precision fermentation technologies to create alternative proteins (Lactoferrin) that can reproduce the same nutritional profiles and sensory experiences as their dairy analogs. Zero Cow Factory, of Indian origin, seeks to complement the traditional dairy industry by producing the first milk and dairy products using bioengineering and microbial fermentation.
Through these investments, says Gabriel Torres, director of Pascual Innoventures, “We intend to strengthen collaboration agreements to launch new products with novel and expanded functionality, which improve the quality of life of our consumers and allow us to enter new markets. Together with De Novo Dairy, we will explore the production of Lactoferrin, a high-value protein, essential in the development of babies and a strengthener of the immune system. Together with Zero Cow, we will work on the synthesis of Casein, a milk protein vital to achieve a good flavor and texture of non-animal origin cheeses or yogurt “.
Cell cultures and precision fermentation techniques are starting to demonstrate industrial viability, as evidenced by the growth of investment in this sector (currently more than 200 investors are identified) and the emergence of new startups using these technologies as a base, whose total business value now exceeds $5.316 million, according to Dealroom data.
In short, this is a sector whose ecosystem is evolving rapidly and generating significant investment traction, both globally and locally. This is supported by the numbers, with investment in dairy alternatives that tripled in 2021 compared to the previous year, from US$194 million to US$605 million.
cloud technology axon
Bridges has agreed to sell VivaGym Group, a leading Iberian operator o...
